Dynamic Profile of CD4 T-Cell-Associated Cytokines/Chemokines Following Murine Myocardial Infarction/Reperfusion
Overview
Pathology
Authors
Affiliations
CD4 T-cells play crucial roles in the injured heart. However, the way in which different CD4 T subtypes function in the myocardial infarction/reperfusion (MI/R) heart is still poorly understood. We aimed to detect the dynamic profile of distinct CD4 subpopulation-associated cytokines/chemokines by relying on a closed-chest acute murine MI/R model. The protein levels of 26 CD4 T-cell-associated cytokines/chemokines were detected in the heart tissues and serum of mice at day 7 and day 14 post-MI/R or sham surgery. The mRNA levels of IL-4, IL-6, IL-13, IL-27, MIP-1, MCP-3, and GRO- were measured in blood mononuclear cells. The protein levels of IL-4, IL-6, IL-13, IL-27, MIP-1, MCP-3, and GRO- increased in both injured heart tissues and serum, while IFN-, IL-12P70, IL-2, IL-1, IL-18, TNF-, IL-5, IL-9, IL-17A, IL-23, IL-10, eotaxin, MIP-1, RANTES, MCP-1, and MIP-2 increased only in MI/R heart tissues in the day 7 and day 14 groups compared to the sham group. In serum, the IFN-, IL-23, and IL-10 levels were downregulated in the MI/R model at both day 7 and day 14 compared to the sham. Compared with the protein expressions in injured heart tissues at day 7, IFN-, IL-12P70, IL-2, IL-18, TNF-, IL-6, IL-4, IL-5, IL-9, IL-17A, IL-23, IL-27, IL-10, eotaxin, IP-10, RANTES, MCP-1, MCP-3, and GRO- were reduced, while IL-1 and MIP-2 were elevated at day 14. IL-13 and MIP-1 showed higher levels in the MI/R serum at day 14 than at day 7. mRNA levels of IL-4, IL-6, IL-13, and IL-27 were increased in the day 7 group compared to the sham, while MIP-1, MCP-3, and GRO- mRNA levels showed no significant difference between the MI/R and sham groups in blood mononuclear cells. Multiple CD4 T-cell-associated cytokines/chemokines were upregulated in the MI/R hearts at the chronic stage. These results provided important evidence necessary for developing future immunomodulatory therapies after MI/R.
CCL11 (Eotaxin) Promotes the Advancement of Aging-Related Cardiovascular Diseases.
Zhang T, Huang Y, Ji X, Wu T, Xiao P Rev Cardiovasc Med. 2025; 26(2):26020.
PMID: 40026499 PMC: 11868897. DOI: 10.31083/RCM26020.
Kologrivova I, Kercheva M, Panteleev O, Ryabov V Biomedicines. 2024; 12(9).
PMID: 39335587 PMC: 11428626. DOI: 10.3390/biomedicines12092073.
Causal effects of inflammatory cytokines on cardiovascular diseases: Insights from genetic evidence.
Chen Y, Zhong A Heliyon. 2024; 10(15):e35447.
PMID: 39165962 PMC: 11334864. DOI: 10.1016/j.heliyon.2024.e35447.
Chen R, Bao Q, Ma X PLoS One. 2024; 19(8):e0308081.
PMID: 39088580 PMC: 11293651. DOI: 10.1371/journal.pone.0308081.
The roles of Th cells in myocardial infarction.
Liu J, Liu F, Liang T, Zhou Y, Su X, Li X Cell Death Discov. 2024; 10(1):287.
PMID: 38879568 PMC: 11180143. DOI: 10.1038/s41420-024-02064-6.